CL2019003739A1 - Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats. - Google Patents

Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats.

Info

Publication number
CL2019003739A1
CL2019003739A1 CL2019003739A CL2019003739A CL2019003739A1 CL 2019003739 A1 CL2019003739 A1 CL 2019003739A1 CL 2019003739 A CL2019003739 A CL 2019003739A CL 2019003739 A CL2019003739 A CL 2019003739A CL 2019003739 A1 CL2019003739 A1 CL 2019003739A1
Authority
CL
Chile
Prior art keywords
probiotic
pediococcus
lactobacillus
cats
prevention
Prior art date
Application number
CL2019003739A
Other languages
Spanish (es)
Inventor
Roberto Toledo Alonso Jorge
Rayen Quilodrán Vega Sandra
Andrés Sandoval Sandoval Felipe
Esteban Aguirre Calfante Alex
Cecilia Portillo Henriquez Brigida
Javier Ramírez Valenzuela Francisco
Isabel Pino Binimelis Ana
Fabiola Fernández Elgueta Katherina
César Villena Julio
Albarracín Leonardo
Original Assignee
Univ Concepcion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Concepcion filed Critical Univ Concepcion
Priority to CL2019003739A priority Critical patent/CL2019003739A1/en
Publication of CL2019003739A1 publication Critical patent/CL2019003739A1/en
Priority to PCT/CL2020/050128 priority patent/WO2021119868A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se presenta la cepa probiótica de Lactobacillus sp. RGM 2852 y la cepa probiótica de Pediococcus sp. RGM 2609, y el uso de ambas en la elaboración de una formulación probiótica para la prevención de diarreas causadas por patógenos bacterianos que afectan a perros y gatos. Esta formulación puede presentarse como un polvo granulado liofilizado o en forma de microcápsulas, los que al ser soluble en agua u otros líquidos permite disponer de las cepas probioticas en alimentos para mascotas, ya sean líquidos o jaleas.The probiotic strain of Lactobacillus sp. RGM 2852 and the probiotic strain of Pediococcus sp. RGM 2609, and the use of both in the preparation of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats. This formulation can be presented as a lyophilized granulated powder or in the form of microcapsules, which, being soluble in water or other liquids, allow the probiotic strains to be used in pet food, whether they are liquids or jellies.

CL2019003739A 2019-12-18 2019-12-18 Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats. CL2019003739A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2019003739A CL2019003739A1 (en) 2019-12-18 2019-12-18 Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats.
PCT/CL2020/050128 WO2021119868A1 (en) 2019-12-18 2020-10-13 Probiotic strains of lactobacillus sp. and of pediococcus sp. and use thereof in the preparation of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2019003739A CL2019003739A1 (en) 2019-12-18 2019-12-18 Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats.

Publications (1)

Publication Number Publication Date
CL2019003739A1 true CL2019003739A1 (en) 2020-06-19

Family

ID=71143869

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019003739A CL2019003739A1 (en) 2019-12-18 2019-12-18 Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats.

Country Status (2)

Country Link
CL (1) CL2019003739A1 (en)
WO (1) WO2021119868A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117467581B (en) * 2023-12-22 2024-03-08 山东威曼宠物食品有限公司 Pediococcus acidilactici King73 capable of improving canine immunity and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60119515T2 (en) * 2000-05-25 2007-05-24 Société des Produits Nestlé S.A. PROBIOTICA FOR USE AS PET FOOD
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
FI128916B (en) * 2018-02-05 2021-03-15 Vetcare Oy Health beneficial composition and method for the preparation thereof

Also Published As

Publication number Publication date
WO2021119868A1 (en) 2021-06-24

Similar Documents

Publication Publication Date Title
ES2408279B1 (en) PROBIOTIC LACTIC ACID BACTERIA
CO2018013557A2 (en) Compositions comprising bacterial strains
AR110684A1 (en) COMPOSITIONS THAT INCLUDE BACTERIAL VINTAGES AND TREATMENT METHOD
DOP2017000137A (en) BENZAMIDES SUBSTITUTED WITH 1,3-THIAZOL-2-ILO.
CL2012001950A1 (en) Use of a probiotic bacterial strain in the manufacture of a medicament or nutritional composition in humans or animals to alter sleep patterns
CL2019002640A1 (en) Proprietary molecules to reduce virulence of pathogens.
BR112013031325A2 (en) spray-dried lactobacillus strains and cells and their use against helicobacter pylori
CL2014002348A1 (en) Phenicol derived compounds; pharmaceutical composition that includes them; and its use to control or treat bacterial infections in cattle.
BR112014004515A2 (en) "antibacterial compounds, their use, pharmaceutical composition and therapeutic combination comprising them"
CL2018001936A1 (en) New probiotic bacterial strain of lactobacillus plantarum and its compositions and uses in the treatment of inflammation.
RU2015105738A (en) NON-PATHOGENIC STRAIN F18 E. COLI AND ITS APPLICATION
AR102085A1 (en) NUTRITIONAL COMPOSITION FOR THE GASTROINTESTINAL ENVIRONMENT FOR THE PROVISION OF AN IMPROVED METABOLIC PROFILE AND MICROBIOMA
UA112551C2 (en) BACTERIOPHAGA STRAIN AND ITS APPLICATION
CL2013000994A1 (en) Use of chelating agent and peptide antimicrobial compounds because it serves to inhibit the growth of and / or kill a plant pathogenic microorganism in a plant; composition comprising chelating agent and an antimicrobial agent.
CO2021017317A2 (en) Safe and invisible cells for the immune system
CL2019003739A1 (en) Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats.
CL2020001975A1 (en) Compositions and methods of use of novel strains of lactobacillus fermentum. (divisional request 201801680)
CL2013000991A1 (en) Composition comprising blad microbial polypeptide or active variant thereof; use of said composition to kill or inhibit the growth of a microorganism that is human or animal pathogen.
BR112018074107A2 (en) method for reducing egg contamination
CL2015003616A1 (en) Piscirickettsia salmonis strain deposited under the registration number dms 27338; vaccine that includes it; use to prevent infection by p. salmonis; and culture medium for p. salmonis
CL2015001457A1 (en) Symbiotic composition comprising a bifidobacterium probiotic strain and an oligosaccharide component comprising arabino xyl oligosaccharides, useful for inhibiting infection by pathogens in the colon; and food composition that comprises it.
AR101538A1 (en) BACTERIAL VINETS THAT HAVE ANTIMICROBIAL ACTIVITY AND BIOCONTROL COMPOSITIONS THAT UNDERSTAND THEM
BR112017027899A2 (en) compositions and methods of use of lamellar bodies for therapeutic purposes
UY38350A (en) PROLONGED AND CONTINUOUS RELEASE COMPOSITIONS TO SUPPORT PLANT HEALTH AND METHODS OF USE
BR112016029890A2 (en) use of hydrothermally treated biomass as a pathogen binder